Zoetis' relfovetmab product is a long-acting anti-nerve growth factor monoclonal therapy for cats. “The benefits of Portela are significantly improved scores as assessed by cat owners using ...

No one wants to see their cats suffer unnecessarily, whether it’s with chronic pain or stress-induced anxiety. Owners should be aware that gabapentin is a common medication used to help mitigate these ...

Portela becomes first mAb therapy with a three-month dosing interval approved for the alleviation of pain associated with OA ...

Zombie cats – that is how some people describe their pets on an opioid pain medication. The FDA has received hundreds of reports of cat deaths linked to the drug. Channel 2 investigative reporter ...

According to Zomedica, a diagnostic and therapeutic products company, Assisi Loop Lounge is a bed that can relieve pain and inflammation for treatment and post-surgery recovery, provide comfort for ...

While Americans have long loved their dogs and cats, recent data shows that many regard their pets as family members and are willing to spend accordingly, particularly on veterinary healthcare. This ...

Zoetis Inc. today announced that the European Commission has granted the company marketing authorization for Portela (relfovetmab), making it the first monoclonal antibody (mAb) therapy with a three-m ...